Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kinnate Biopharma Inc.

    NASDAQ: KNTE · Real-Time Price · USD
    2.65
    -0.01 (-0.38%)
    At close: Apr 02, 2024, 10:00 PM

    Kinnate Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 799K 604K 123K
    Gross Profit
    		 -799K -604K -123K
    Operating Income
    		 -119.01M -118.52M -90.11M
    Interest Income
    		 8.53M n/a 348K
    Pretax Income
    		 -112.65M -116.27M -89.76M
    Net Income
    		 -112.65M -114.02M -89.42M
    Selling & General & Admin
    		 27.44M 30.37M 22.95M
    Research & Development
    		 90.77M 88.15M 67.17M
    Other Expenses
    		 n/a n/a 348K
    Operating Expenses
    		 118.21M 118.52M 90.11M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 119.01M 118.52M 90.11M
    Income Tax Expense
    		 n/a -2.25M -348K
    Shares Outstanding (Basic)
    		 46.58M 44.07M 43.6M
    Shares Outstanding (Diluted)
    		 46.58M 44.07M 43.6M
    EPS (Basic)
    		 -2.42 -2.59 -2.05
    EPS (Diluted)
    		 -2.42 -2.59 -2.05
    EBITDA
    		 -118.21M -117.92M -89.99M
    EBIT
    		 -119.01M -118.52M -90.11M
    Depreciation & Amortization
    		 799K 604K 123K

    Add to Watchlist